Coronaviruses: An overview with special emphasis on COVID-19 outbreak with musculoskeletal manifestations

Ali, Shahid; Singh, Ajai; Sharief, N.; Yadav, Manish; Siddiqui, Salma; Pandey, Vaishnavi; Raikwar, Archana; Singh, Anamika

doi:10.5312/wjo.v12.i9.620

Cited by 4 publications

(4 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Twenty literature reviews were identified2, 12-30 . Of the remaining studies, 31 presented original research 31-61 , 6 were case series 62-67 , 24 were case reports 68-91 , 1 provided a specialist’s opinion 92 , 4 were editorials 93-96 , and 2 were letters to the editor 97,98 .…”

Section: Resultsmentioning

confidence: 99%

What Do We Need to Know About Musculoskeletal Manifestations of COVID-19?

et al. 2022

View full text Add to dashboard Cite

COVID-19 is a disease that is challenging science, health-care systems, and humanity. An astonishingly wide spectrum of manifestations of multiorgan damage, including musculoskeletal, can be associated with SARS-CoV-2. » In the acute phase of COVID-19, fatigue, myalgia, and arthralgia are the most common musculoskeletal symptoms.» Post-COVID-19 syndrome is a group of signs and symptoms that are present for .12 weeks. The associated musculoskeletal manifestations are fatigue, arthralgia, myalgia, new-onset back pain, muscle weakness, and poor physical performance.» Data on COVID-19 complications are growing due to large absolute numbers of cases and survivors in these 2 years of the pandemic. Additional musculoskeletal manifestations encountered are falls by the elderly, increased mortality after hip fracture, reduced bone mineral density and osteoporosis, acute sarcopenia, rhabdomyolysis, Guillain-Barr é syndrome, muscle denervation atrophy, fibromyalgia, rheumatological disease triggering, septic arthritis, adhesive capsulitis, myositis, critical illness myopathy, onset of latent muscular dystrophy, osteonecrosis, soft-tissue abscess, urticarial vasculitis with musculoskeletal manifestations, and necrotizing autoimmune myositis.

show abstract

Section: Resultsmentioning

confidence: 99%

What Do We Need to Know About Musculoskeletal Manifestations of COVID-19?

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The COVID-19 pandemic was a major challenge for health services worldwide, burdening them with a new, initially unknown demand [ 1 , 2 ]. Due to the abrupt changes, it can be observed that services still have insufficient infrastructure in the outpatient care of people with sequelae of COVID-19 [ 3 , 4 ].…”

Section: Introductionmentioning

confidence: 99%

Musculoskeletal pain during and after SARS-CoV-2 infection and healthcare utilization: a cross-sectional study

de Oliveira Soares Junior,

dos Santos Afonso,

Vieira

et al. 2023

BMC Musculoskelet Disord

View full text Add to dashboard Cite

Background The COVID-19 pandemic necessitated the reorganization of health services to cater to the needs of individuals affected by the virus. Objective This study aimed to examine the association between musculoskeletal pain during and after SARS-CoV-2 infection and the utilization of health services among adults in southern Brazil. Methods A cross-sectional study was conducted with individuals aged 18 years and older, who were diagnosed with COVID-19 between December 2020 and March 2021. Questionnaires were electronically collected using tablets through the REDCap platform via phone calls. The health service utilization outcomes assessed included Primary Health Care, general practitioners, private emergency care, and specialized services. The exposure variable was the presence of musculoskeletal pain during and after SARS-CoV-2 infection in different regions, such as cervical, upper limbs, thoracic, lumbar, and lower limbs. Poisson regression analysis was employed to assess the relationship between health service utilization during and after SARS-CoV-2 infection and musculoskeletal pain during and after the infection with SARS-CoV-2 among adults in southern Brazil. Data were analyzed using the Stata 16.1 statistical package. Results A total of 2,919 individuals were interviewed. Overall, individuals with musculoskeletal pain were found to utilize health services approximately 15 percentage points higher when compared to those without musculoskeletal pain. In adjusted analysis, individuals who reported musculoskeletal pain during and after SARS-CoV-2 infection were up to twice as likely to use health services. Among them, the emergency care unit was the most frequently used service, particularly in those with pain in the lower limbs (RP=2.19, 95% CI 1.66-2.87) and thoracic region (RP=2.04, 95% CI 1.47-2.84). Notably, the highest magnitudes of association were observed with emergency care units, specialist doctors, and specialized services, especially neurologists, who were two to three times more likely to be sought, followed by pulmonologists. Conclusion Health service utilization was significantly associated with musculoskeletal pain during and after SARS-CoV-2 infection. All regions, except for the cervical region, showed a correlation with the use of Primary Health Care. The thoracic region featured an association with pulmonologists and emergency room utilization. Additionally, health services like emergency care units, specialist doctors, and specialized services, including cardiologists and neurologists, were commonly utilized across all regions in southern Brazil.

show abstract

“…COVID-19 was first described in patients from China in December 2019, and it rapidly became evident in the first months of 2020 that the disease was spreading dramatically around the world, leading to a major global pandemic situation. The first described symptoms of COVID-19 involved the lungs, with respiratory symptoms as the leading manifestation, ranging from acute fever, cough, dyspnea to mild pneumonia or severe illness with respiratory distress ( 1 ). With the evolution of the pandemic and the emergence of new strains of the virus, there was growing evidence that the virus could induce various clinical manifestations, such as gastrointestinal, cardiovascular, neurological, dermatological, hematological, and musculoskeletal symptoms ( 2 – 4 ).…”

mentioning

confidence: 99%

“…One relevant question is the susceptibility of patients with IRD to COVID-19 and, in particular, the risk of developing a severe form of the disease, taking into account the immune deregulation of these conditions and the immunosuppressive medications that patients receive, especially biologic agents ( 1 , 2 ). Previous European cohorts were reassuring on these concerns, and some specific treatments have been associated with a risk of severe disease, i.e., glucocorticoids, mycophenolate mofetil, and certain biologics such as rituximab ( 10 ).…”

mentioning

confidence: 99%

Editorial: Impact and consequences of COVID-19 on the musculoskeletal system

Toussirot,

Maglio,

Fini

et al. 2023

Front. Med.

View full text Add to dashboard Cite

Coronaviruses: An overview with special emphasis on COVID-19 outbreak with musculoskeletal manifestations

Cited by 4 publications

References 37 publications

What Do We Need to Know About Musculoskeletal Manifestations of COVID-19?

What Do We Need to Know About Musculoskeletal Manifestations of COVID-19?

Musculoskeletal pain during and after SARS-CoV-2 infection and healthcare utilization: a cross-sectional study

Editorial: Impact and consequences of COVID-19 on the musculoskeletal system

Contact Info

Product

Resources

About